• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: methodological details.印度医学研究理事会-印度糖尿病(ICMR-INDIAB)研究:方法学细节。
J Diabetes Sci Technol. 2011 Jul 1;5(4):906-14. doi: 10.1177/193229681100500413.
2
Analysis of the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study.印度医学研究理事会-印度糖尿病(ICMR-INDIAB)研究分析。
J Diabetes Sci Technol. 2011 Jul 1;5(4):915-7. doi: 10.1177/193229681100500414.
3
Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).印度代谢性非传染性疾病健康报告:ICMR-INDIAB 国家横断面研究(ICMR-INDIAB-17)。
Lancet Diabetes Endocrinol. 2023 Jul;11(7):474-489. doi: 10.1016/S2213-8587(23)00119-5. Epub 2023 Jun 7.
4
Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study.印度自我报告糖尿病患者达到指南推荐的糖尿病治疗目标和健康习惯的情况(ICMR-INDIAB-13):一项全国性横断面研究。
Lancet Diabetes Endocrinol. 2022 Jun;10(6):430-441. doi: 10.1016/S2213-8587(22)00072-9. Epub 2022 Apr 21.
5
Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.印度医学研究理事会-印度糖尿病(ICMR-INDIAB)研究城乡印度糖尿病和糖尿病前期(空腹血糖受损和/或糖耐量受损)患病率:I 期结果。
Diabetologia. 2011 Dec;54(12):3022-7. doi: 10.1007/s00125-011-2291-5. Epub 2011 Sep 30.
6
Glycemic control among individuals with self-reported diabetes in India--the ICMR-INDIAB Study.印度自我报告患有糖尿病个体的血糖控制——印度医学研究理事会-印度糖尿病研究(ICMR-INDIAB研究)
Diabetes Technol Ther. 2014 Sep;16(9):596-603. doi: 10.1089/dia.2014.0018. Epub 2014 Aug 7.
7
Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.印度 15 个邦的糖尿病和糖尿病前期患病率:ICMR-INDIAB 基于人群的横断面研究结果。
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596. doi: 10.1016/S2213-8587(17)30174-2. Epub 2017 Jun 7.
8
Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study.印度城乡血脂异常患病率:印度医学研究理事会-印度生物样本库研究
PLoS One. 2014 May 9;9(5):e96808. doi: 10.1371/journal.pone.0096808. eCollection 2014.
9
Physical activity and inactivity patterns in India - results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5].印度的身体活动与不活动模式 - ICMR-INDIAB 研究(第 1 阶段)[ICMR-INDIAB-5]的结果。
Int J Behav Nutr Phys Act. 2014 Feb 26;11(1):26. doi: 10.1186/1479-5868-11-26.
10
Effect of internal migration on diabetes and metabolic abnormalities in India - The ICMR-INDIAB study.国内迁移对印度糖尿病和代谢异常的影响——ICMR-INDIAB 研究。
J Diabetes Complications. 2021 Dec;35(12):108051. doi: 10.1016/j.jdiacomp.2021.108051. Epub 2021 Sep 25.

引用本文的文献

1
Quality of life in patients with diabetes in a Rural Health and Training Centre.农村健康与培训中心糖尿病患者的生活质量
J Family Med Prim Care. 2025 Jul;14(7):2826-2830. doi: 10.4103/jfmpc.jfmpc_2115_24. Epub 2025 Jul 21.
2
Prevalence of undernutrition in children with cancer in low-income and middle-income countries: a systematic review.低收入和中等收入国家癌症患儿的营养不良患病率:一项系统评价。
BMJ Glob Health. 2025 Jun 19;10(6):e019345. doi: 10.1136/bmjgh-2025-019345.
3
Understanding Epidemiology of Physical Activity and Sedentary Behaviour Among Adults in Haryana: Insights from the ICMR-INDIAB Study [ICMR-INDIAB-19].了解哈里亚纳邦成年人身体活动和久坐行为的流行病学:来自印度医学研究理事会-印度成年人生物医学研究(ICMR-INDIAB)研究[ICMR-INDIAB-19]的见解。
Adv Ther. 2025 May 13. doi: 10.1007/s12325-025-03200-z.
4
Cultural Aspects of Type-2 Diabetes-related Social Stigma: A Cultural Epidemiological Study among General Community Members in Urban Pune, India.2型糖尿病相关社会耻辱感的文化层面:印度浦那市普通社区成员的文化流行病学研究
Indian J Community Med. 2025 Jan-Feb;50(1):234-241. doi: 10.4103/ijcm.ijcm_894_22. Epub 2025 Jan 23.
5
Lessons Learned From Epidemiology of Type 2 Diabetes in South Asians: Kelly West Award Lecture 2024.从南亚2型糖尿病流行病学中汲取的经验教训:2024年凯利·韦斯特奖讲座
Diabetes Care. 2025 Feb 1;48(2):153-163. doi: 10.2337/dci24-0046.
6
ICMR-MDRF Diabetes Biosamples: Cohort profile.印度医学研究理事会-多药耐药性糖尿病生物样本:队列简介。
Indian J Med Res. 2024 Nov;160(5):514-526. doi: 10.25259/IJMR_1036_2024.
7
Assessment of burden of prediabetes and diabetes with oral glucose tolerance test in community-based settings of Bengaluru rural district.在班加罗尔农村地区的社区环境中,通过口服葡萄糖耐量试验评估糖尿病前期和糖尿病的负担。
J Family Med Prim Care. 2024 Sep;13(9):3806-3814. doi: 10.4103/jfmpc.jfmpc_9_24. Epub 2024 Sep 11.
8
Urban-Rural Differences in the Prevalence of Diabetes Among Adults in Haryana, India: The ICMR-INDIAB Study (ICMR-INDIAB-18).印度哈里亚纳邦成年人糖尿病患病率的城乡差异:印度医学研究理事会-印度糖尿病研究(ICMR-INDIAB-18)
Diabetes Ther. 2024 Jul;15(7):1597-1613. doi: 10.1007/s13300-024-01602-w. Epub 2024 May 21.
9
Mitochondrial Dysfunction and Imeglimin: A New Ray of Hope for the Treatment of Type-2 Diabetes Mellitus.线粒体功能障碍与依美格鲁辛:2型糖尿病治疗的新希望之光。
Mini Rev Med Chem. 2024;24(17):1575-1589. doi: 10.2174/0113895575260225230921062013.
10
Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India.达格列净与恩格列净在印度2型糖尿病患者中的安全性和疗效比较。
Rev Assoc Med Bras (1992). 2023 Aug 14;69(8):e20230090. doi: 10.1590/1806-9282.20230090. eCollection 2023.

本文引用的文献

1
The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes.印度需要获得准确的全国糖尿病患病率估计值-全国糖尿病研究的基本原理。
Indian J Med Res. 2011 Apr;133(4):369-80.
2
Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries.在发展中国家的流行病学研究中,比较毛细血管全血与静脉血浆葡萄糖估测值在筛查糖尿病中的应用。
Diabetes Technol Ther. 2011 May;13(5):586-91. doi: 10.1089/dia.2010.0218. Epub 2011 Mar 15.
3
High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India.印度糖尿病和心血管危险因素的高患病率与城市化相关。
Diabetes Care. 2008 May;31(5):893-8. doi: 10.2337/dc07-1207. Epub 2008 Feb 29.
4
Reproducibility and validity of an interviewer-administered semi-quantitative food frequency questionnaire to assess dietary intake of urban adults in southern India.由访谈员实施的半定量食物频率问卷用于评估印度南部城市成年人饮食摄入量的可重复性和有效性。
Int J Food Sci Nutr. 2006 Nov-Dec;57(7-8):481-93. doi: 10.1080/09637480600969220.
5
Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17).印度南部城市糖尿病和糖耐量受损患病率的长期趋势——金奈城乡流行病学研究(CURES-17)
Diabetologia. 2006 Jun;49(6):1175-8. doi: 10.1007/s00125-006-0219-2. Epub 2006 Mar 29.
6
The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS).采用世界卫生组织1999年标准评估印度糖尿病和糖耐量受损负担:印度糖尿病患病率研究(PODIS)
Diabetes Res Clin Pract. 2004 Dec;66(3):301-7. doi: 10.1016/j.diabres.2004.04.008.
7
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.美国国家高血压预防、检测、评估与治疗联合委员会第七次报告:JNC 7报告。
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
8
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.印度糖尿病和糖耐量受损的高患病率:全国城市糖尿病调查
Diabetologia. 2001 Sep;44(9):1094-101. doi: 10.1007/s001250100627.
9
Intra-urban differences in the prevalence of the metabolic syndrome in southern India -- the Chennai Urban Population Study (CUPS No. 4).印度南部城市代谢综合征患病率的城市内部差异——金奈城市人口研究(第4号金奈城市人口研究)
Diabet Med. 2001 Apr;18(4):280-7. doi: 10.1046/j.1464-5491.2001.00421.x.
10
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划(NCEP)成人高血胆固醇检测、评估与治疗专家小组第三次报告(成人治疗小组第三次报告)执行摘要
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.

印度医学研究理事会-印度糖尿病(ICMR-INDIAB)研究:方法学细节。

The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: methodological details.

作者信息

Anjana Ranjit Mohan, Pradeepa Rajendra, Deepa Mohan, Datta Manjula, Sudha Vasudevan, Unnikrishnan Ranjit, Nath Lalith M, Das Ashok Kumar, Madhu Sri Venkata, Rao Paturi Vishnupriya, Shukla Deepak Kumar, Kaur Tanvir, Ali Mohammed K, Mohan Viswanathan

机构信息

Madras Diabetes Research Foundation, Dr. Mohan's Diabetes Specialities Centre, WHO Collaborating Centre for Noncommunicable Diseases Prevention and Control, IDF Centre of Education, Chennai, India.

出版信息

J Diabetes Sci Technol. 2011 Jul 1;5(4):906-14. doi: 10.1177/193229681100500413.

DOI:10.1177/193229681100500413
PMID:21880233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3192597/
Abstract

BACKGROUND

Currently available estimates of diabetes prevalence in India are based on published data derived from very few studies. The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study is a community-based survey conceived with the aim of obtaining the prevalence rates of diabetes in India as a whole, covering all 28 states, the National Capital Territory of Delhi, and two of the union territories in the mainland of India, with a total sample size of 124,000 individuals.

METHODS

A stratified multistage sampling design has been used. In all study subjects, a structured questionnaire was administered and anthropometric parameters and blood pressure were measured. Fasting capillary blood glucose was first determined using a glucose meter. An oral glucose load was then administered to all subjects except those with self-reported diabetes, and the 2 h post-load capillary blood glucose was estimated. In every fifth subject, a fasting venous sample was collected for measurement of lipids and creatinine, a resting 12-lead electrocardiogram was performed, and dietary assessment questionnaire was administered. In all diabetic subjects, an additional diabetes questionnaire was used and a fasting venous sample drawn for glycated hemoglobin.

RESULTS

All biological samples collected were analyzed in a central laboratory. All data collected were stored electronically. Quality control was achieved through multiple tiers of checks.

CONCLUSIONS

The ICMR-INDIAB study is the first of its kind attempting to provide accurate and comprehensive state- and national-level data on diabetes prevalence in India.

摘要

背景

目前印度糖尿病患病率的现有估计是基于极少数研究得出的已发表数据。印度医学研究理事会 - 印度糖尿病(ICMR - INDIAB)研究是一项基于社区的调查,旨在获取整个印度的糖尿病患病率,涵盖所有28个邦、德里国家首都辖区以及印度大陆的两个联邦属地,总样本量为124,000人。

方法

采用分层多阶段抽样设计。对所有研究对象发放结构化问卷,并测量人体测量参数和血压。首先使用血糖仪测定空腹毛细血管血糖。然后除了自我报告患有糖尿病的患者外,对所有受试者进行口服葡萄糖耐量试验,并估算服糖后2小时毛细血管血糖。每五名受试者中,采集一份空腹静脉血样用于检测血脂和肌酐,进行一次静息12导联心电图检查,并发放饮食评估问卷。对所有糖尿病患者,使用额外的糖尿病问卷,并采集一份空腹静脉血样用于检测糖化血红蛋白。

结果

所有采集的生物样本均在中央实验室进行分析。所有收集的数据均以电子方式存储。通过多层检查实现了质量控制。

结论

ICMR - INDIAB研究是同类研究中首个尝试提供印度糖尿病患病率准确且全面的邦级和国家级数据的研究。